Innovate Today – Preserve the latest vaccine, pharmaceutical, or nutraceutical on our PaletteStrip™
Meet Global Demand
The current pandemic has highlighted the need for a vaccine delivery in a cost-effective reliable manner on a global basis. Utilizing PaletteStrip™, it would only require 18 tractor-trailers to vaccinate the entire world population.
we solve the immune challenge
CA Pharma was created in 2005 to manufacture film. From experience in film for confectionery, vitamins, energy strips, melatonin, and thyroid aid we have developed a process for putting many actives and adjuvants together on a thin film strip.
This unique, oral, sublingual film strip (PaletteStrip™) can be applied to a broad spectrum of applications including vaccines, pharmaceutical or nutraceuticals and others.
This new approach or delivery method to immunization is mucosal. This technology is administered orally in the correct dosage, at the same absorption or better than an injection intramuscularly.
A FEW WORDS FROM OUR INDUSTRY EXPERT
“Not only will this new approach to immunization likely prove to be far more efficacious than the current conventional methods, but it’s impact on global health will, with certainty, be immense in so many other ways. Indeed, the development and ultimate utilization of this technology should be considered a public health imperative.“
DR. Michael E. Shannon
Former Deputy Surgeon General & Director General of Laboratory Centers for Disease Control, Canada. Consultant, CA Pharma.
0 M+
STRIPS/DAY PRODUCTION*
$ 1 B
~2027 Vaccine Market Size*
The PaletteStrip™ Advantage
Many have developed film strips for single flavours and actives. Processes for putting many actives and adjuvants together has not been achieved while maintaining stability, a shelf life, without cold storage, inexpensive packaging, all at less cost. CA Pharma has!
Our game changer benefits from:
- Preserving multiple actives into a single dose regardless of biochemical incompatibility.
- No complicated storage; long shelf life; no refrigeration; efficacious absorption.
- Less costly to manufacture with significant environmental savings.
We have a successful history of streamlined manufacturing process, formulation, and affordability with confectionery (such as breathe strips), vitamins, energy strips, melatonin, thyroid aid
Initial Confirmation - IPV POLIO D ANTIGEN
CA Pharma has received initial confirmation of preservation of IPV Polio D Antigen.
Broad Spectrum
The PaletteStrip™ enables the efficient creations of a broad spectrum of products such as vaccines, pharmaceuticals, nutraceuticals. This will change immunization as we know it.
Our product development team can create and aid in specific formulations of sublingual PaletteStrip™ formulations to meet client specifications.
IN SUBLINGUAL STRIP TECHNOLOGY
Get In Touch
Welcoming Industry & Academia
Contact us
Current challenges are to ensure the availability of vaccines to achieve their maximum impact on global health while enhancing the uptake of the old EPI vaccines (polio, tuberculosis, measles, etc.) even further throughout the populations that has been attained so far. CA Pharma's product line resolves vaccine pre-order, supply bottleneck, and remote area distribution & administration difficulties.
Competing mucosal strips have large manufacturing overhead and conventionally utilize a 'sandwhich' approach of attempting to preserve actives. Conventionally these competing products have failed. CA Pharma is able to segregate multiple actives into a single dose - previously unheard of.
Overall, mucosal administration offers better absorption as it bypasses the stomach and other organs that may contribute to a breakdown of the active. Due to this, certain actives may require a smaller dose to perform the same effect.
While effective - these routes of administration tend to be costly to package, expensive to ship and contain, costly to administer, and have limited and costly life span control. The maintenance of these routes also provide a friction point.
Nasal and buccal sprays can be difficult to control the amount of dose, additionally mechanical faults can complicate dosing. Apart from these, nasal and buccal sprays are costly to package, and have a limited and costly life span control.
You can reach out directly and we would be more than happy to answer any and all inquiries. Please note that we will be launching a much larger website within Q1 of 2022.
What's Going On In Our Blog?
at this stage to enable us to quote as necessary
The New Celanese Chief Pushes Customer-Facing Strategy
KBR links with L&T for refinery and petrochemical projects
Lean service well operations with HR practices incorporated
Successfully driving the value mechanisms for digitally
